Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Include Ingredient Firms In GMP Identity-Testing Exemptions – Trade Groups

This article was originally published in The Tan Sheet

Executive Summary

FDA should allow ingredient suppliers as well as product manufacturers to petition for exemptions from 100 percent identity testing of ingredients as required by the dietary supplement good manufacturing practices final rule, industry trade groups say in comments on the interim final rule for establishing the exemptions process

You may also be interested in...



GMP Supplier Qualification Appears More Viable Route Than Testing

While FDA allows supplement manufacturers to use "full testing" of ingredients as an alternative to the supplier qualification process, qualifying still appears to be the most viable and economical approach to GMP compliance

GMP Supplier Qualification Appears More Viable Route Than Testing

While FDA allows supplement manufacturers to use "full testing" of ingredients as an alternative to the supplier qualification process, qualifying still appears to be the most viable and economical approach to GMP compliance

GMP Supplier Qualification Appears More Viable Route Than Testing

While FDA allows supplement manufacturers to use "full testing" of ingredients as an alternative to the supplier qualification process, qualifying still appears to be the most viable and economical approach to GMP compliance

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101046

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel